Pages that link to "Q52926628"

The following pages link to Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma. (Q52926628):

Displaying 11 items.

• Antidepressive Effect of Mirtazapine in Post-Myocardial Infarction Depression Is Associated with Soluble TNF-R1 Increase: Data from the MIND-IT (Q33791816) (← links)
• Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigue (Q35048091) (← links)
• Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C (Q35231633) (← links)
• Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents. (Q36052673) (← links)
• Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior (Q36111806) (← links)
• Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression (Q37126943) (← links)
• Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface (Q37351319) (← links)
• Immune-related biomarkers for diagnosis/prognosis and therapy monitoring of cutaneous melanoma. (Q37801939) (← links)
• Rapid Regulation of Depression-Associated Genes in a New Mouse Model Mimicking Interferon-α-Related Depression in Hepatitis C Virus Infection (Q42197754) (← links)
• Persistent pro‐inflammatory cytokines following the initiation of pegylated IFN therapy in hepatitis C infection is associated with treatment‐induced depression (Q48949896) (← links)
• Increased soluble tumor necrosis factor-alpha receptors in patients with major depressive disorder. (Q51660386) (← links)